insights_auto
Why is BIAF down 8.44%?
Dive Deeperchevron_right
BIAF:NASDAQ
bioAffinity Technologies Inc
$5.64
arrow_downward
-8.44%(-0.52) 1D
$5.61
arrow_downward
-0.53% (-0.030)bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIAF...
Open
$6.35
High
$9.38
Low
$5.50
Mkt. cap
6.58M
Avg. vol.
6.24M
Volume
35.05M
52-wk high
$80.70
52-wk low
$4.56
EPS
-$103.35
Beta
-1.25
Shares outstanding
1.17M
No. of employees
57
Open
$6.35
High
$9.38
Low
$5.50
Mkt. cap
6.58M
Avg. vol.
6.24M
Volume
35.05M
52-wk high
$80.70
52-wk low
$4.56
EPS
-$103.35
Beta
-1.25
Shares outstanding
1.17M
No. of employees
57
News stories
From web sources and news partners
PR Newswire
·
2 hours ago
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
StreetInsider
·
4 hours ago
bioAffinity Technologies plans $4M stock offering on Nasdaq
Yahoo Finance
·
5 hours ago
bioAffinity Technologies Receives Japanese Patent Allowance for CyPath Lung AI Diagnostic Test
TipRanks
·
6 hours ago
bioAffinity Secures Japanese Patent for CyPath Lung
About bioAffinity Technologies Inc
CEO-
Employees57
Founded2014
HeadquartersSan Antonio, Texas, United States
SectorBiotechnology
Website-